A report on the outbreak of Zika virus on Easter Island, South Pacific, 2014
- First Online:
- Cite this article as:
- Tognarelli, J., Ulloa, S., Villagra, E. et al. Arch Virol (2016) 161: 665. doi:10.1007/s00705-015-2695-5
- 4.5k Downloads
Zika virus (ZIKV) is an emerging mosquito-borne flavivirus circulating in Asia and Africa. In 2013, a large outbreak was reported on the archipelago of French Polynesia. In this study, we report the detection and molecular characterization of Zika virus for the first time in Chile from an outbreak among the inhabitants of Easter Island. A total of 89 samples from patients suspected of having ZIKV infection were collected between the period from January to May, 2014. Molecular diagnosis of the virus was performed by RT-PCR followed by the sequencing of the region containing the NS5 gene. A comparison of the viral nucleic acid sequence with those of other strains of ZIKA virus was performed using the MEGA software. Fifty-one samples were found positive for ZIKV by RT-PCR analysis. Further analysis of the NS5 gene revealed that the ZIKV strains identified in Easter Island were most closely related to those found in French Polynesia (99.8 to 99.9 % nt and 100 % aa sequence identity). These results strongly suggest that the transmission pathway leading to the introduction of Zika virus on Easter Island has its origin in French Polynesia.
KeywordsZika virus Easter Island Outbreak South Pacific ZIKV
Zika virus (ZIKV) is a mosquito-borne virus belonging to the family Flaviviridae and the genus Flavivirus. The Flaviviruses also include yellow fever, dengue, St. Louis encephalitis, West Nile, and Japanese encephalitis viruses . ZIKV was first isolated from the blood of a sentinel rhesus monkey inhabiting the Zika Forest in Uganda . Later on, ZIKV was isolated from a mosquito of the species Aedes africanus, obtained from the same locality of the Zika Forest. ZIKV has been isolated from several species of Aedes mosquito, notably, A. aegypti and A. albopictus . A. aegypti is widely distributed in tropical and subtropical regions of the world [6, 11, 12].
Clinically diagnosed ZIKV infections in human cases have been reported to include self-limiting acute febrile illnesses with fever, headache, myalgia, retro-orbital pain, arthralgia, conjunctivitis, and rash. These clinical presentations closely resemble those that are caused by dengue virus (DENV) and Chikungunya virus . Serological studies and isolation of ZIKV strains have subsequently indicated that the virus has a wide geographical distribution, including regions in East and West Africa, South and South East Asia, and Micronesia , where an outbreak of Zika fever was reported on Yap Island . In 2013, a Zika fever outbreak in French Polynesia was the largest ever reported for an arbovirus other than DENV at this location. Following this, there was a report of a Zika outbreak on the Cook Islands of New Caledonia [3, 12].
In Chile, at the end of 2000, the presence of A. aegypti on Easter Island was reported; the island is located on the east edge of the Polynesian Triangle, in the south Pacific Ocean, with a latitude of 27° 9′ 10” S, and a longitude of 109° 27′ 17” W . The closest continental point from this island is the Chilean coast, located at a distance of 3,800 km. All of the inhabitants (3,860) of this island live in a single rural village, Hanga Roa, on the western coast of Easter Island. In the year 2002, the first outbreak of dengue virus serotype 1 was reported, with 636 diagnosed cases of dengue fever [2, 13]. Subsequently, during surveillance activities on Easter Island in 2009, two cases of infection with dengue virus serotype 4 were detected . Since the report of the first case of dengue virus, active surveillance for acute febrile illness has been coordinated by the Epidemiology Department of the Ministry of Health, with the active participation of the Hospital of Hanga Roa—the only health center located on the island, which also serves as a public health institute.
Here, we report the identification of ZIKV as the causative agent of the outbreak that started in January 2014 on Easter Island. A total of 89 blood samples were collected from suspected ZIKV-infected human patients who visited the emergency unit service of Hanga Roa Hospital, as they were being treated as suspected cases during the period from January to May 30, 2014. These patients complained of fever and maculopapular erythematous rash within the first five days after the onset of symptoms, along with at least one of the following symptoms: conjunctival hyperemia, arthralgia, and myalgia. For each patient, vital parameters such as age and sex, clinical presentation, the date and time of onset of symptoms, the date of sample collection, and the history of travel were recorded.
In order to confirm the diagnosis of suspected ZIKV infection, 5 mL of venous whole blood was collected from all of the suspected patients. The blood samples were centrifuged at 1500 × g for 10 min, and the sera obtained were stored at -20 °C until further analysis. All of the serum samples were sent to the Public Health Institute of Chile for further virological analysis.
Viral RNA was extracted from 300 µL of serum using an easyMAG extraction system (bioMérieux) . A nested RT-PCR-based method described by Kuno et al.  was developed by the Public Health Institute of Chile to analyze the samples. In this study, a patient was considered positive for ZIKV if the sample tested positive in the RT-PCR analysis described above.
The amplicons generated from the NS5 genes were sequenced in both directions using a BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems, Foster City, CA, USA). Nucleotide sequences were obtained using an ABI PRISM 3500 Genetic Analyzer (Applied Biosystems). The sequence data were assembled and edited electronically using the Seqman, EditSeq and MegAlign programs (DNASTAR, Madison, WI). A maximum-likelihood (ML) phylogenetic tree was constructed for the NS5 gene with the K2 + G + I model using MEGA6 software .
A total of 89 serum samples from cases of suspected ZIKV infection cases were tested by RT-PCR. Of these, 51 samples tested positive for ZIKA. The ZIKV-negative serum samples were re-extracted and re-tested by nested RT-PCR. All of them tested negative for ZIKV when re-tested. The 51 ZIKA-positive cases in the present study corresponded to 42 adult (>16 years) patients, and the rest (9 cases) were children (<15 years). Thirty-three (64 %) patients were female, and 18 (36 %) were male. None of the patients reported a history of recent travel outside the island. All of the samples (89) tested negative for dengue virus in real-time RT-PCR as described elsewhere .
Cao-Lormeau et al. reported the largest outbreak caused by an arbovirus other than DENV on the islands of French Polynesia . They estimated that the number of suspected ZIKV infections was around 28,000 in February 2014, and the Easter Island index case was detected in January 2014. Based on the results obtained in this study, we assume that the transmission pathway for the introduction of ZIKV on Easter Island had its origin in French Polynesia.
Here, we report an outbreak of ZIKV for the first time on Easter Island. The results obtained in this study confirm the necessity of maintaining active virological and epidemiological surveillance on Easter Island due to the continuing risk posed by DENV and ZIKV. Furthermore, these findings documenting the spread of ZIKV have important public-health implications for the continued spread of this dengue-like disease, potentially to the western hemisphere.
We thank María Ibañez Aravena, Mauro Arancibia and Liliana Ramos from the Subdepartment of Molecular Genetics of the Public Health Institute for excellent technical assistance. This study was supported by the Public Health Institute.